TTS Pharma Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$341K
- Investors
-
4
TTS Pharma General Information
Description
Operator of cannabinoid products intended to become the leading European supplier of clean cannabinoids to the food, cosmetics, and nutraceutical markets. The company separates and purifies the various components in bulk form ready for use as an Active Pharmaceutical Ingredient (API) also works within existing legislation, enabling consumers to get quality and safe products for the ethical cannabis market.
Contact Information
Website
www.ttspharma.comCorporate Office
- Liverpool Science Park
- 131 Mount Pleasant
- Liverpool L3 5TF
- England, United Kingdom
Corporate Office
- Liverpool Science Park
- 131 Mount Pleasant
- Liverpool L3 5TF
- England, United Kingdom
TTS Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 22-Oct-2021 | $341K | Completed | Generating Revenue | ||
| 6. Later Stage VC | 31-Jan-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 23-May-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 31-Jan-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Nov-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 25-Oct-2013 | $620K | $1.5M | Completed | Startup | |
| 1. Early Stage VC | 26-Nov-2012 | $878K | $878K | Completed | Startup |
TTS Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| B Ordinary | ||||||||
| A Ordinary | ||||||||
| B Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| B Ordinary | ||||||||
| A Ordinary | 45,178 | $0.000136 | $22.74 | $22.74 | 1x | $22.74 | 0.78% | |
| Ordinary | 133,484 | $0.000136 | $22.74 | $22.74 | 1x | $22.74 | 2.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TTS Pharma Comparisons
Industry
Financing
Details
TTS Pharma Competitors (7)
One of TTS Pharma’s 7 competitors is GVB Biopharma, a Formerly VC-backed company based in Las Vegas, NV.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GVB Biopharma | Formerly VC-backed | Las Vegas, NV | ||||
| Brains Bioceutical | Venture Capital-Backed | Vancouver, Canada | ||||
| Mile High Labs | Venture Capital-Backed | Broomfield, CO | ||||
| Aurora Biosciences | Formerly VC-backed | San Diego, CA | ||||
| Canopy Growth | Formerly Accelerator/Incubator backed | Smiths Falls, Canada |
TTS Pharma Patents
TTS Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4489736-A1 | A cannabinoid mixture with terpenes for the treatment of anxiety | Pending | 08-Feb-2022 | ||
| US-20250381204-A1 | A cannabinoid mixture with terpenes for the treatment of anxiety | Pending | 08-Feb-2022 | ||
| WO-2023152477-A1 | A cannabinoid mixture with terpenes for the treatment of anxiety | Inactive | 08-Feb-2022 | ||
| EP-4288038-A2 | A cannabinoid mixture | Pending | 08-Feb-2021 | ||
| GB-202101732-D0 | A cannabinoid mixture | Inactive | 08-Feb-2021 | A61K31/658 |
TTS Pharma Signals
TTS Pharma Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Future Fund (UK) | Lender/Debt Provider | Minority | ||
| The North West Fund | Venture Capital | Minority | ||
| European Investment Bank | Investment Bank | Minority | ||
| Spark Impact | Corporate Venture Capital | Minority |
TTS Pharma Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Medisonal Group | London, United Kingdom | 2019 | |
| Endopure | Liverpool, United Kingdom | 2017 | |
| Tts Manufacturing | Liverpool, United Kingdom | 2017 |
TTS Pharma FAQs
-
When was TTS Pharma founded?
TTS Pharma was founded in 2012.
-
Where is TTS Pharma headquartered?
TTS Pharma is headquartered in Liverpool, United Kingdom.
-
What is the size of TTS Pharma?
TTS Pharma has 4 total employees.
-
What industry is TTS Pharma in?
TTS Pharma’s primary industry is Pharmaceuticals.
-
Is TTS Pharma a private or public company?
TTS Pharma is a Private company.
-
What is the current valuation of TTS Pharma?
The current valuation of TTS Pharma is .
-
What is TTS Pharma’s current revenue?
The current revenue for TTS Pharma is .
-
How much funding has TTS Pharma raised over time?
TTS Pharma has raised $31.7M.
-
Who are TTS Pharma’s investors?
Future Fund (UK), The North West Fund, European Investment Bank, and Spark Impact have invested in TTS Pharma.
-
Who are TTS Pharma’s competitors?
GVB Biopharma, Brains Bioceutical, Mile High Labs, Aurora Biosciences, and Canopy Growth are some of the 7 competitors of TTS Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process